1. Home
  2. ESTC vs BIO Comparison

ESTC vs BIO Comparison

Compare ESTC & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Elastic N.V.

ESTC

Elastic N.V.

N/A

Current Price

$51.88

Market Cap

5.6B

Sector

Technology

ML Signal

N/A

Logo Bio-Rad Laboratories Inc.

BIO

Bio-Rad Laboratories Inc.

N/A

Current Price

$269.07

Market Cap

7.2B

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
ESTC
BIO
Founded
2012
1952
Country
Netherlands
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Laboratory Analytical Instruments
Sector
Technology
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
5.6B
7.2B
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
ESTC
BIO
Price
$51.88
$269.07
Analyst Decision
Buy
Strong Buy
Analyst Count
27
4
Target Price
$94.08
$358.50
AVG Volume (30 Days)
2.4M
304.0K
Earning Date
05-28-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,483,296,000.00
N/A
Revenue This Year
$19.19
$2.51
Revenue Next Year
$13.46
$3.17
P/E Ratio
N/A
$9.72
Revenue Growth
17.04
N/A
52 Week Low
$49.90
$211.43
52 Week High
$103.79
$343.12

Technical Indicators

Market Signals
Indicator
ESTC
BIO
Relative Strength Index (RSI) 37.09 37.86
Support Level $49.90 $266.71
Resistance Level $91.19 $290.01
Average True Range (ATR) 3.29 7.21
MACD 0.06 0.67
Stochastic Oscillator 13.17 13.13

Price Performance

Historical Comparison
ESTC
BIO

About ESTC Elastic N.V.

Elastic is a software company that specializes in AI-search, observability, and security deployments. Its search division offers both traditional keyword search and vector search methods to enable more context-aware querying. The software has open-source origins but generates revenue through valuable add-ons, including simplified data orchestration and server scaling techniques.

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Share on Social Networks: